Age-related macular degeneration (AMD) is the leading cause of blindness among older adults. The exudative or ‘wet’ form of the disease is characterized by the growth of abnormal blood vessels from ...

A study published today by the European Journal of Pharmaceutics and Biopharmaceutics reveals that cannabidiol (CBD) ...

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...

Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...

Vision loss is a growing concern in India, especially macular degeneration - a common eye condition. Once known to be ...

UNITY anticipates the complete 36-week data results of the remaining patients in the second quarter of 2025.

Once under the skin, the crystals assemble into a drug "depot" that could last for months or years, eliminating the need for ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading dose of a minimum of three monthly intravitreal aflibercept injections that ...